Jeffrey Jerome Ludwig, Chief Commercial Officer at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 25,912 shares at $4.49 ($116K) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Scheduled sale ($116k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.49 | 12,956 | $58K | 50.0% |
| 2 | $4.49 | 12,956 | $58K | 50.0% |
| Total | $4.49 avg | 25,912 | $116K | 100% |
| Filing → |
| PBYI | SELL | 2024-07-02 | $20K | — | Filing → |
| PBYI | SELL | 2023-07-06 | $40K | — | Filing → |
| PBYI | SELL | 2023-01-05 | $27K | — | Filing → |